Distinct GPCRs are uniquely over-expressed in the WNT and SHH subgroups, as well as in three other groups of tumors, strongly suggesting that GPCR targets specific to each medulloblastoma subgroup can be identified. The gene discussed is LPAR3; the disease is medulloblastoma.